Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients.
Clinical trial NCT06655662 · RECRUITING
Trial details
- NCT number
- NCT06655662
- Sponsor
- Shenzhen Hemogen
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-12
- Primary completion
- 2025-12-31
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.